1 Andrés Muñoz, MD, PhD, Medical Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain; Eduardo Salas, MD, PhD, Transfer Technology Office, Fundació Institut de Bioenginyeria de Catalunya (IBEC), Barcelona, Spain; and José Manuel Soria, PhD, BSc, Genomics of Complex Diseases Unit, Biomedical Research Institute Sant Pau (IIB-Sant Pau), Barcelona, Spain.